Atlas Trials

The Randomized Study of Dasatinib and High-Dose Imatinib (600mg) in Suboptimal Responder

Clinical trial NCT00854841 · AVAILABLE

Trial details

NCT number
NCT00854841
Sponsor
Pusan National University Hospital
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Chronic Myeloid Leukemia

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.